Viewing Study NCT01956695


Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2025-12-29 @ 11:27 PM
Study NCT ID: NCT01956695
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2013-09-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma
Sponsor: Institut Curie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module